-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
August 19th, Kingsley Biotech (hereinafter: Kingsley) and Somerset Technologies (hereinafter referred to as Seymru) announced that they will jointly launch a comprehensive cooperation in the field of life sciences and biopharmaceuticals to jointly promote the development of the entire industrial chain of biopharmaceuticals from research and development to production. According to the terms of the agreement, Seymru will provide kingsley with quality services in product, process optimization services, supply chain optimization services, personnel training, quality control system construction, etc.Kingsley has a leading and complete platform in the field of biopharmacerie from drug discovery to commercial production, and continues to maintain capacity expansion investment, and continuously improve its leading position in the field of biopharmacerie. In July 2019, the Kingsley Biopharmaceity Research and Development and Production Center was put into operation, and biopharmaceity development services entered a new milestone phase.
Kingsley and Seymru have a long history of working in the life sciences. With Kingsley's business expansion into the field of biopharmaceutical customization development, the cooperation between the two sides also further strategic upgrading, this strategic cooperation will rely on ThermoFei in the field of biopharmaceutical advanced products, technologies and services, combined with Kingsley super biopharmaceutical custom development platform, more standardized and more efficient service customers, thereby helping the entire biopharmaceutical industry industrial development. (Medical Valley)